Showing results (261-270 of 363) with videos related to

Sort By:
Pageof 37
Journal for Immunotherapy of Cancer|July 16, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancerMatthew D Galsky, Arjun V Balar, Peter C Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2017
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder CancerGillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Surgical management of stage T1 renal tumours at Canadian academic centresLuke T Lavallée, Simon Tanguay, Michael A Jewett, et al.
European Urology|November 7, 2020
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell TumorsLucia Nappi, Marisa Thi, Nabil Adra, et al.
The Journal of Urology|October 17, 2022
Obesity and Complication Risk From Radical Cystectomy: Identifying a Body Mass Index ThresholdLouise Catherine McLoughlin, Wassim Kassouf, Rodney H Breau, et al.
Clinical Genitourinary Cancer|May 11, 2021
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched AnalysisMarina Deuker, Marieke J Krimphove, L Franziska Stolzenbach, et al.
European Urology|December 27, 2021
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder CancerMathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, et al.
The Journal of Urology|March 19, 2013
Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLaWolfgang Jäger, Yutaka Horiguchi, Jay Shah, et al.
Molecular Cancer Therapeutics|August 28, 2020
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder CancerYoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, et al.
The Journal of Urology|October 13, 2021
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant ChemotherapyYair Lotan, Joep J de Jong, Vinnie Y T Liu, et al.
Pageof 37